MARKET

AEMD

AEMD

Aethlon Medical
NASDAQ
1.450
+0.260
+21.85%
After Hours: 1.280 -0.17 -11.72% 17:09 07/09 EDT
OPEN
1.190
PREV CLOSE
1.190
HIGH
1.580
LOW
1.160
VOLUME
5.22M
TURNOVER
--
52 WEEK HIGH
8.44
52 WEEK LOW
1.100
MARKET CAP
3.75M
P/E (TTM)
-0.1690
1D
5D
1M
3M
1Y
5Y
1D
Aethlon Medical Price Target Announced at $1.50/Share by HC Wainwright & Co.
Dow Jones · 2d ago
Aethlon Medical Coverage Assumed by HC Wainwright & Co. at Neutral
Dow Jones · 2d ago
HC Wainwright & Co. Assumes Aethlon Medical at Neutral, Announces Price Target of $1.5
Benzinga · 2d ago
Weekly Report: what happened at AEMD last week (0630-0704)?
Weekly Report · 2d ago
Aethlon Medical: Hold Rating Amidst Promising Technology and Financial Challenges
TipRanks · 2d ago
Aethlon Medical assumed with a Neutral at H.C. Wainwright
TipRanks · 2d ago
Aethlon’s Earnings Call: Clinical Progress Amid Financial Hurdles
TipRanks · 6d ago
Weekly Report: what happened at AEMD last week (0623-0627)?
Weekly Report · 06/30 11:19
More
About AEMD
Aethlon Medical, Inc. is a medical therapeutic company focused on developing the Hemopurifier, a clinical-stage immunotherapeutic device which is designed to combat cancer and life-threatening viral infections and for use in organ transplantation. The Hemopurifier, in pre-clinical studies, has demonstrated the removal of harmful exosomes from biological fluids, utilizing its lectin-based technology. The Hemopurifier is a United States Food and Drug Administration (FDA) designated Breakthrough Device indicated for the treatment of individuals with advanced or metastatic cancer who are either unresponsive to or intolerant of standard of care therapy, and with cancer types in which exosomes have been shown to participate in the development or severity of the disease. The Hemopurifier also holds an FDA Breakthrough Device designation and an open Investigational Device Exemption application related to the treatment of life-threatening viruses that are not addressed with approved therapies.

Webull offers Aethlon Medical Inc stock information, including NASDAQ: AEMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AEMD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AEMD stock methods without spending real money on the virtual paper trading platform.